PharmAust Limited (PAA.AX)
AUD 0.23
(6.98%)
AUD 0.23
(6.98%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.16 Million | -1.56 Million | -1.33 Million | -937.96 Thousand | -1.27 Million | -1.55 Million |
| Net Income | -8.89 Million | -6.21 Million | -1.7 Million | -1.33 Million | -1.36 Million | -1.55 Million |
| Depreciation & Amortization | 1641.00 | 326.54 Thousand | 314.92 Thousand | 298.26 Thousand | 274.63 Thousand | 172.43 Thousand |
| Deferred income taxes | - | -365.71 Thousand | -517.17 Thousand | -844.3 Thousand | -998.13 Thousand | 196.35 Thousand |
| Stock-based compensation | - | -10 Thousand | -46.33 Thousand | 155.01 Thousand | 48.25 Thousand | -148.06 Thousand |
| Change in working capital | 253 Thousand | 240.69 Thousand | 74.83 Thousand | -99.82 Thousand | -327.48 Thousand | -48.29 Thousand |
| Other non-cash items | 2.81 Million | 4.45 Million | 549.69 Thousand | 890.19 Thousand | 1.09 Million | -175.21 Thousand |
| Investing Cash Flow | -1.16 Million | -34.93 Thousand | -43.37 Thousand | -138.03 Thousand | -30.22 Thousand | -146.72 Thousand |
| Investments in PPE | -3.00 | -34.93 Thousand | -43.37 Thousand | -138.03 Thousand | -30.22 Thousand | -146.72 Thousand |
| Acquisitions | -165.22 Thousand | - | - | - | - | - |
| Investment purchases | -1 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -167.00 | - | -36.31 Thousand | - | - |
| Financing Cash Flow | 13.34 Million | 1.88 Million | 770.99 Thousand | 1.21 Million | 2.09 Million | 1.91 Million |
| Debt repayment | - | -354.33 Thousand | -210.11 Thousand | -320.73 Thousand | -294.02 Thousand | -101.02 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.3 Million | 2.24 Million | 718.49 Thousand | 1.53 Million | 2.38 Million | 2.01 Million |
| Other Financing Activities | 35 Thousand | 1.88 Million | 262.6 Thousand | 1.21 Million | 2.09 Million | 1.00 |
| Accounts receivables | 138.9 Thousand | -40.89 Thousand | 56.62 Thousand | 55.73 Thousand | -38.84 Thousand | -10.48 Thousand |
| Accounts payables | 528.27 Thousand | 322.48 Thousand | 44.63 Thousand | 2006.00 | -116.01 Thousand | 56.19 Thousand |
| Inventory | - | -4219.00 | -34.92 Thousand | -150.5 Thousand | -245.75 Thousand | -37.8 Thousand |
| Other working capital | -414.17 Thousand | -36.68 Thousand | 8497.00 | -7060.00 | 73.12 Thousand | -56.19 Thousand |
| Cash at beginning of period | 2.7 Million | 2.41 Million | 3.02 Million | 2.88 Million | 2.09 Million | 1.87 Million |
| Cash at end of period | 9.71 Million | 2.7 Million | 2.41 Million | 3.02 Million | 2.88 Million | 2.09 Million |
| Capital Expenditure | -3.00 | -34.93 Thousand | -43.37 Thousand | -138.03 Thousand | -30.22 Thousand | -146.72 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 7 Million | 290.32 Thousand | -604.65 Thousand | 139.77 Thousand | 789.87 Thousand | 215.19 Thousand |
| Free Cash Flow | -5.16 Million | -1.59 Million | -1.37 Million | -1.07 Million | -1.3 Million | -1.7 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.29 Million | -8.89 Million | -1.6 Million | -6.19 Million | -6.21 Million | -21.18 Thousand |
| Depreciation & Amortization | 1641.00 | 1641.00 | - | 163.05 Thousand | 326.54 Thousand | 163.49 Thousand |
| Deferred income taxes | - | - | - | -363.5 Thousand | -365.71 Thousand | - |
| Stock-based compensation | - | - | 76.61 Thousand | 82.5 Thousand | -10 Thousand | -92.5 Thousand |
| Change in working capital | - | 253 Thousand | - | -81.79 Thousand | 240.69 Thousand | - |
| Other non-cash items | 2.17 Million | 2.81 Million | 1.55 Million | 4.86 Million | 4.45 Million | 108.29 Thousand |
| Investing Cash Flow | -1 Million | -1.16 Million | -165.22 Thousand | -34.5 Thousand | -34.93 Thousand | -428.00 |
| Investments in PPE | -5.00 | - | - | -34.5 Thousand | -34.93 Thousand | -428.00 |
| Acquisitions | - | -165.22 Thousand | -165.22 Thousand | - | - | - |
| Investment purchases | -1 Million | -1 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -165.22 Thousand | 1.00 | -167.00 | -168.00 |
| Financing Cash Flow | 10.38 Million | 13.34 Million | 2.95 Million | 2.16 Million | 1.88 Million | -277.21 Thousand |
| Debt repayment | - | - | - | - | -354.33 Thousand | -210.11 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.34 Million | 13.3 Million | 2.95 Million | 2.24 Million | 2.24 Million | - |
| Other Financing Activities | 35 Thousand | 35 Thousand | 2.95 Million | 2.16 Million | 1.88 Million | -277.21 Thousand |
| Accounts receivables | - | 138.9 Thousand | - | -40.89 Thousand | -40.89 Thousand | - |
| Accounts payables | - | 528.27 Thousand | - | - | 322.48 Thousand | - |
| Inventory | - | - | - | -4219.00 | -4219.00 | - |
| Other working capital | - | -414.17 Thousand | - | -36.68 Thousand | -36.68 Thousand | - |
| Cash at beginning of period | 5.45 Million | 2.7 Million | 2.7 Million | 2.06 Million | 2.41 Million | 2.41 Million |
| Cash at end of period | 9.71 Million | 9.71 Million | 5.45 Million | 2.7 Million | 2.7 Million | 2.06 Million |
| Capital Expenditure | -5.00 | - | - | -34.5 Thousand | -34.93 Thousand | -428.00 |
| Effect of forex changes on cash | - | - | 2.7 Million | -2.7 Million | - | 2.41 Million |
| Net cash flow / Change in cash | 4.26 Million | 7 Million | 2.74 Million | 644.35 Thousand | 290.32 Thousand | -354.02 Thousand |
| Free Cash Flow | -5.12 Million | -5.16 Million | -47.27 Thousand | -1.52 Million | -1.59 Million | -76.81 Thousand |
INCREDIBLE
VMART
CHLLTD
DV8
GUJCMDS
600774